Table 3.
Laboratory outcomes
| Laboratory outcomes in the intent‐to‐treat study populations | Groups | ||||
|---|---|---|---|---|---|
| EBV (n = 5) | EBV + MSC (n = 5) | ||||
| Time point | Baseline | D90 | Baseline | D90 | p value |
| PaO2 (mmHg) | 75 (22.7) | 66.6 (27.5) | 60.8 (5.5) | 67.2 (11.2) | .82 |
| PaCO2 (mmHg) | 60 (30.8) | 52.2 (24.6) | 43.3 (0.2) | 40.5 (7.1) | .56 |
| Glucose (mg/dl) | 85 (17.1) | 104.3 (25.7) | 105 (13.9) | 104.3 (25.7) | .93 |
| Sodium (mmol/l) | 141 (1.4) | 140.8 (2.6) | 140.8 (2.6) | 140.8 (1.6) | .99 |
| Potassium (mmol/l) | 4.6 (0.8) | 4.4 (0.9) | 4.4 (0.3) | 4.4 (0.5) | .94 |
| Urea (mg/dl) | 46.2 (23.8) | 38.8 (17.9) | 42.3 (4.0) | 42 (13.4) | .93 |
| Creatinine (mg/dl) | 0.4 (0.1) | 0.7 (0.1) | 0.9 (0.3) | 0.9 (0.2) | .52 |
Data are presented as mean (SD).
Abbreviations: EBV, endobronchial valve; MSC, mesenchymal stromal cells.